Equities research analysts expect Correvio Pharma Corp (NASDAQ:CORV) to report sales of $8.20 million for the current fiscal quarter, according to Zacks Investment Research. Three analysts have provided estimates for Correvio Pharma’s earnings. The lowest sales estimate is $7.70 million and the highest is $8.80 million. Correvio Pharma posted sales of $6.18 million during the […]